The isolation of VCAM-1+ endothelial cell-derived extracellular vesicles using microfluidics
2024

Isolating Endothelial Cell-Derived Extracellular Vesicles Using Microfluidics

publication Evidence: moderate

Author Information

Author(s): Akbar Naveed, Luciani Evelyn Grace, Ahmad Raheel, Lee Dasol, Veiga Sara, Rabe Daniel Christopher, Stott Shannon Leigh

Primary Institution: University of Oxford; Massachusetts General Hospital Cancer Center, Harvard Medical School

Hypothesis

Can the EVHB-Chip effectively isolate VCAM-1+ endothelial cell-derived extracellular vesicles for analysis?

Conclusion

The study demonstrates a novel method for isolating VCAM-1+ extracellular vesicles, which may enhance understanding of their role in cardiovascular and metabolic diseases.

Supporting Evidence

  • VCAM-1+ endothelial cell-derived extracellular vesicles are increased in cardiovascular disease.
  • The EVHB-Chip showed significant binding to VCAM-1+ cells compared to control devices.
  • TNF-α stimulation increased VCAM-1 levels in endothelial cells.
  • Captured extracellular vesicles were positive for known EV markers like CD9 and CD63.

Takeaway

Researchers created a special chip to catch tiny bubbles from blood cells that can help us understand heart diseases better.

Methodology

The study used a microfluidic device coated with anti-VCAM-1 antibodies to selectively capture VCAM-1+ endothelial cells and their derived extracellular vesicles.

Potential Biases

Potential variability in antibody concentrations and efficiency in capturing VCAM-1+ EVs.

Limitations

The study primarily focuses on in vitro experiments, and further in vivo investigations are necessary to validate findings in physiologically relevant settings.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.20517/evcna.2023.51

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication